Skinvisible Q2 FY26 net loss narrows to USD 255,533; revenue flat at USD 5,000

Reuters2026/08/13 18:42

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Skinvisible posted a net loss of USD 255,533 for Q2 2026, narrowing from a loss of USD 274,427 a year earlier.
Revenue held flat at USD 5,000 versus the prior-year quarter, while operating expenses fell to USD 117,817 from USD 141,237.
Interest expense drove other expenses of USD 142,716, little changed from USD 142,720 in the year-ago quarter.
Working capital deficit widened to USD 5.5 million at June 30, 2026, from USD 4.99 million at Dec. 31, 2025.
Quoin’s QRX003 remains on track for Phase 3 recruitment completion by end-2026, with a potential FDA filing targeted for 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Skinvisible Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001663577-26-000248), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Skinvisible Q2 FY26 net loss narrows to USD 255,533; revenue flat at USD 5,000

You may also like

Crypto prices